Continuing a trend for large pharma to entrust vast swathes of their clinical tials, to a single CRO partner, Merck Serono has signed a new, five-year agreement with Quintiles to form a “single, well-aligned clinical development engine”.
More on SCRIP Intellignece May 24th 2013 No 3650